Top News

NEW YORK, Dec. 10, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the...

ROSEN, A LEADING LAW FIRM, Encourages Vintage Wine Estates, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – VWE

NEW YORK, Dec. 10, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers...

ROSEN, A LEADING NATIONAL FIRM, Encourages Unisys Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – UIS

NEW YORK, Dec. 10, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...

ROSEN, A LEADING AND RANKED FIRM, Encourages Polished.com Inc. f/k/a 1847 Goedeker Inc. Investors With Losses to Secure Counsel Before Important December 30 Deadline in First Filed Securities Class Action Commenced by the Firm – POL, GOED

NEW YORK, Dec. 10, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of...

Over $100,000 Raised by Robert and Michelle’s Annual Holiday Party and Gift Drive Benefitting Speak Up for Kids and 1,600 Foster Children

Placing foster children at the forefront, Robert and Michelle's Annual Holiday Party engages the community and holiday spirit to spread...

Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022

$Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022$

- A total of 17 pediatric patients were treated with STRO-002 on a compassionate use basis; eight patients achieved complete...

Kura Oncology Presents Updated Clinical Data from KOMET-001 Trial of Menin Inhibitor Ziftomenib at American Society of Hematology Annual Meeting

– 30% CR rate at 600 mg in 20 patients with relapsed/refractory NPM1-mutant AML –– Low frequency of differentiation syndrome,...

SGLY Class Action Deadline Alert: Johnson Fistel Encourages Shareholders to Submit Their Singularity Losses

SAN DIEGO, Dec. 10, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action...

Adaptive Biotechnologies Highlights New Data Showcasing the Clinical Utility of clonoSEQ® MRD Testing in Patients with Blood Cancers at the 64th ASH Annual Meeting